Concepedia

70 A Randomized, Double-Blind, Placebo-Controlled Phase II Study (MOT114479) to Evaluate the Safety and Efficacy and Dose Response of 28 Days of Orally Administered Camicinal, a Motilin Receptor Agonist, in Diabetics With Gastroparesis

Matthew E. Barton, Tal Otiker, Lakshmi Vasist Johnson, Darren Robertson, Robert L. Dobbins, Henry P. Parkman, Per M. Hellström, Jan Tack, Braden Kuo, Anthony Hobson,

Gastroenterology · 2014 · 34 citations · 0 references

Concepts

MedicinePharmacologyPharmacotherapyClinical PharmacologyDiabetologyGastrointestinal PharmacotherapyDiabetes ManagementDiabetes MellitusDiabetes PharmacotherapyGastrointestinal PharmacologyDiabetic Gastroparesis TreatmentDose ResponseGastroparesis PharmacotherapyMotilin PhysiologyMotilin Receptor AgonistsPlacebo-controlled Efficacy Assessment